| 12312352 |
Use of a DPP-4 inhibitor in SIRS and/or sepsis |
Thomas KLEIN, Andreas DAIBER, Michael Mark, Thomas MUENZEL |
2025-05-27 |
| 12171767 |
Uses of DPP IV inhibitors |
Frank Himmelsbach, Michael Mark |
2024-12-24 |
| 11291668 |
Uses of DPP IV inhibitors |
Frank Himmelsbach, Michael Mark |
2022-04-05 |
| 10092571 |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
Eva Ulrike GRAEFE-MODY, Michael Mark, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING |
2018-10-09 |
| 10080754 |
Uses of DPP IV inhibitors |
Frank Himmelsbach, Michael Mark |
2018-09-25 |
| 10034877 |
Treatment for diabetes in patients inappropriate for metformin therapy |
Eva Ulrike GRAEFE-MODY, Ruth HARPER, Hans-Juergen WOERLE |
2018-07-31 |
| 9486526 |
Treatment for diabetes in patients inappropriate for metformin therapy |
Eva Ulrike GRAEFE-MODY, Ruth HARPER, Hans-Juergen WOERLE |
2016-11-08 |
| 9457029 |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
Eva Ulrike GRAEFE-MODY, Michael Mark, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING |
2016-10-04 |
| 9173859 |
Uses of DPP IV inhibitors |
Frank Himmelsbach, Michael Mark |
2015-11-03 |
| 8853156 |
Treatment for diabetes in patients inappropriate for metformin therapy |
Eva Ulrike GRAEFE-MODY, Ruth HARPER, Hans-Juergen WOERLE |
2014-10-07 |
| 8846695 |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor |
— |
2014-09-30 |
| 8673927 |
Uses of DPP-IV inhibitors |
Frank Himmelsbach, Michael Mark |
2014-03-18 |
| 8551957 |
Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate |
Michael Mark, Leo Thomas, Frank Himmelsbach |
2013-10-08 |
| 8232281 |
Uses of DPP-IV inhibitors |
Frank Himmelsbach, Michael Mark |
2012-07-31 |
| 8202884 |
Treatment of type 2 diabetes |
Andreas Raschig, Juergen Reess, Frank Berger, Laurence Salin |
2012-06-19 |
| 7838500 |
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
Gerd Kraemer, Hans-Juergen Martin, Gebhard Adelgoss, Adil Duran, Peter Eickelmann +6 more |
2010-11-23 |
| 7524822 |
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
Gerd Kraemer, Hans-Juergen Martin, Gebhard Adelgoss, Adil Duran, Peter Eickelmann +6 more |
2009-04-28 |